Overactive bladder Trials in Royal Oak, United States
Conditions / Overactive bladder / Royal Oak, United States
Overactive bladder is a medical condition with active clinical research programs worldwide.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01166438 | Anticholinergic vs. Botox Comparison Study | COMPLETED | PHASE3 |
| NCT01369485 | Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder | COMPLETED | NA |
| NCT00611026 | Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. | COMPLETED | PHASE3 |
| NCT04103450 | Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia | COMPLETED | PHASE3 |
| NCT05422625 | PTNS for Female Patients Suffering From Multiple Sclerosis | TERMINATED | NA |
| NCT00131573 | An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome | COMPLETED | PHASE3 |
| NCT03902080 | Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) | COMPLETED | PHASE3 |
| NCT01868516 | Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder | COMPLETED | PHASE2 |
| NCT03523091 | OnabotulinumtoxinA Bladder Injection Study | TERMINATED | PHASE4 |
| NCT00536484 | Fesoterodine Flexible Dose Study | COMPLETED | PHASE3 |